Skip to main content
NGB InstituteNGB Institute

Leadership & advisors

A multidisciplinary platform for global health innovation.

Our leadership team brings together expertise in global healthcare, longevity medicine, regenerative therapies, preventive healthcare, corporate strategy, regulatory affairs, artificial intelligence, and organizational development. Complementing our leadership are distinguished scientific advisors and collaborations with internationally recognized research institutions, creating a multidisciplinary platform dedicated to advancing precision longevity medicine and translating scientific innovation into clinical practice.

Researchers at work in a laboratory, using pipettes, microscopes, and a biosafety cabinet.

Executive management

The people behind the platform.

Michael Nouri

PhD | Founder, Principal Investor & Visionary Developer

Michael Nouri is a distinguished engineer, technology entrepreneur, real estate developer, investor, and philanthropist whose career spans nearly four decades of innovation, leadership, and transformative business creation across multiple industries, including advanced telecommunications, smart infrastructure, heavy manufacturing, technology systems, business software development, and luxury real estate development.

Dr. Annabelle Manalo Morgan

PhD | Chief Scientific Officer | Neuroscientist | Regenerative Medicine Pioneer | Biotechnology Executive | Longevity Science Strategist

Dr. Annabelle Manalo Morgan is an internationally recognized neuroscientist, cellular biologist, regenerative medicine innovator, and biotechnology executive whose career has been dedicated to advancing the frontiers of human health, longevity science, regenerative medicine, and translational biotechnology. Her work spans neuroscience, stem cell technologies, cellular therapeutics, exosome engineering, peptide innovation, advanced biologics, precision medicine, and biotechnology commercialization.

Oguz Murat Otay

MBA | Executive Director of International Relations & Business Development

Oguz Murat Otay is an international business executive with over 30 years of experience in global business development, strategic partnerships, investment, and cross-border market expansion. As Executive Director of International Relations & Business Development, he leads Nouri Group's international growth initiatives, investor relations, and strategic alliances, advancing the company's global presence in longevity medicine and regenerative healthcare.

Justin Rundle, Esq

Chief Legal & Strategic Affairs Officer | Corporate Counsel | Transaction Architect | Strategic Growth Advisor

Justin Rundle is a distinguished business attorney, trusted strategic advisor, and accomplished transaction architect whose career has been dedicated to helping visionary entrepreneurs, investors, developers, healthcare organizations, and emerging growth companies transform ambitious ideas into scalable, investment-grade enterprises.

Iraida Ermakova

Chief Digital Technology Officer | Data Analytics Specialist | Digital Health Systems Strategist

Iraida Ermakova is a highly accomplished technology executive, data analytics leader, and enterprise systems strategist with extensive experience building and managing large-scale technology platforms for some of the world's most influential technology companies. Her expertise spans artificial intelligence, cloud infrastructure, cybersecurity, enterprise architecture, business intelligence, data engineering, digital transformation, and healthcare technology innovation.

Scientific advisors

Clinical and scientific counsel.

Dr. Annabelle Manalo Morgan

PhD | Chief Scientific Officer | Neuroscientist | Regenerative Medicine Pioneer | Biotechnology Executive | Longevity Science Strategist

Dr. Annabelle Manalo Morgan is an internationally recognized neuroscientist, cellular biologist, regenerative medicine innovator, and biotechnology executive whose career has been dedicated to advancing the frontiers of human health, longevity science, regenerative medicine, and translational biotechnology. Her work spans neuroscience, stem cell technologies, cellular therapeutics, exosome engineering, peptide innovation, advanced biologics, precision medicine, and biotechnology commercialization.

Dr. Ethan Kellum

MD | Orthopedic Surgeon

Dr. Ethan Kellum, MD brings expertise in orthopedic medicine, regenerative therapies, and human performance optimization. His experience working with elite athletes provides a unique perspective on tissue health, injury recovery, and advanced approaches to maintaining physical function and quality of life. As Team Orthopedist and Stem Cell Specialist for the Tennessee Titans, he contributes valuable clinical insight into the evolving field of regenerative medicine.

Dr. Christina Rahm

PhD

Dr. Christina Rahm is a scientific researcher and biotechnology innovator focused on advancing the intersection of nutrition, cellular health, and human optimization. With experience across pharmaceutical, nutraceutical, and biotechnology sectors, she brings expertise in translational science, product development, and emerging approaches to personalized health and longevity.

Dr. Felix Lurye

MD | Orthopedic Surgeon

Dr. Felix Lurye, MD brings expertise in musculoskeletal medicine, regenerative approaches, and advanced clinical care focused on improving patient function and quality of life. His experience in managing complex orthopedic and spine-related conditions supports a multidisciplinary approach to tissue health, recovery, and the future of personalized regenerative medicine.

Dr. Arthur Mikaelian

PhD

Dr. Arthur Mikaelian brings expertise in biotechnology innovation, pharmaceutical research, and the translation of scientific discoveries into health-focused applications. His work in biomedical research and development reflects a commitment to exploring novel therapeutic approaches and advancing next-generation solutions in human health.

Dr. Khaled Diab

MD | Founder & Chief Medical Officer, Diab Longevity | Physician | Longevity, Regenerative Medicine & Human Performance Strategist

Dr. Khaled Diab is a physician, longevity medicine specialist, regenerative medicine practitioner, and human performance strategist dedicated to redefining the future of healthcare through precision medicine, advanced diagnostics, and biological optimization.

Scientific affiliations

Engaged with the global scientific community.

Our organization actively engages with international scientific and medical communities to remain connected with the latest advances in regenerative medicine, cellular therapies, longevity science, and translational healthcare. Membership applications have been submitted to premier global organizations that support scientific exchange, professional education, ethical standards, and the advancement of innovative therapies.

Application submitted

ISSCR

International Society for Stem Cell Research

The International Society for Stem Cell Research (ISSCR) is an international scientific organization dedicated to advancing stem cell biology and regenerative medicine. Its global community includes researchers, clinicians, educators, ethicists, regulators, and industry professionals working to advance scientific discovery, responsible innovation, and the translation of regenerative technologies into clinical applications.

Application submitted

ISCT

International Society for Cell & Gene Therapy

The International Society for Cell & Gene Therapy (ISCT) is a global organization focused on advancing the development, translation, and implementation of cell and gene therapies. ISCT brings together scientists, clinicians, industry leaders, and regulatory experts working to establish safe, scalable, and clinically applicable cellular medicine solutions.

Application submitted

AASCP

American Academy of Stem Cell Physicians

The American Academy of Stem Cell Physicians (AASCP) is a professional organization focused on physician education, clinical training, and the responsible advancement of stem cell-based therapies. AASCP brings together physicians and healthcare professionals interested in the evolving field of regenerative medicine, supporting the exchange of clinical knowledge, treatment methodologies, and emerging scientific developments.

Application submitted

IPS

International Peptide Society

The International Peptide Society (IPS) is a global scientific organization dedicated to advancing research, education, and collaboration in the field of peptide science and peptide-based therapeutics. The Society supports scientists, clinicians, and industry professionals working to understand and develop peptide technologies across healthcare, biotechnology, and personalized medicine.

*Applications pending; listing does not imply membership or endorsement.

Research collaborations

Connected to institutions advancing translational science.

Our institutional research collaborations connect our organization with internationally recognized biomedical research institutions, supporting scientific validation, translational innovation, and the advancement of next-generation longevity and regenerative medicine technologies.

Scripps Research

Independent biomedical research institutions

Scripps Research is a globally recognized biomedical research institution known for discoveries in molecular medicine, immunology, neuroscience, and biotechnology. Its research ecosystem supports the translation of scientific discoveries into innovative solutions that advance the future of human health and longevity.

Images shown are for informational and illustrative purposes only. They are used to represent referenced institutions and facilities and do not imply endorsement, affiliation, or partnership unless expressly stated.

Better science.
Stronger systems.
Healthier generations.

Our multidisciplinary team is dedicated to translating scientific innovation into clinical practice.